Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can exercise enhance lipitor's effect on fat reduction?Can lipitor grapefruit interaction cause any adverse side effects?What's the impact of lipitor on ginseng's body uptake?Are yervoy's side effects more manageable than other cancer treatments?Generic lipitor cost?
See the DrugPatentWatch profile for lipitor
How does Lipitor stop cholesterol production in the liver? Lipitor works by blocking an enzyme called HMG-CoA reductase. This enzyme controls the first step in the liver's pathway that turns acetyl-CoA into cholesterol. When the enzyme is blocked, the liver produces less cholesterol. What happens inside the liver cells after Lipitor binds to the enzyme? Atorvastatin, the active ingredient in Lipitor, binds directly to the active site of HMG-CoA reductase and locks it into an inactive form. The enzyme normally converts HMG-CoA into mevalonate, which is the building block for all subsequent steps. With the enzyme locked, the supply of mevalonate drops,打断 the supply of isoprenoids and squalene that lead to final cholesterol molecules. Does Lipitor affect other parts of the pathway beyond the first step? The drug only stops the pathway at its rate-limiting step. Later stages—converting mevalonate to isoprenoids, squalene, then cholesterol—are still active, but the shortage upstream means less raw material arrives. The pathway does not feedback-activate enough to overcome the shortage created by the blockage. How does the liver compensate once cholesterol synthesis is reduced? The liver increases the number of LDL receptors on its surface to pull more LDL particles from the blood. More blood LDL gets removed, so serum cholesterol levels fall. The combination of less internal production and increased uptake from the blood is what ultimately lowers circulating cholesterol. What happens if the liver keeps trying to boost synthesis despite Lipitor? The liver still tries to compensate by activating sterol-regulatory-element-binding-protein-2 (SREBP-2), which attempts to increase production of HMG-CoA reductase itself. The statin keeps overriding this attempt, so the shortage persists. The attempted compensation does not restore full synthesis. When does the effect on cholesterol synthesis reach steady state? After daily dosing, the steady-state reduction in cholesterol production is reached in about two weeks. At that point both the dire<|eos|>
Other Questions About Lipitor :